The TORCH (TOwards a Revolution in COPD Health) survival study ... 2004年8月1日 - The “TOwards a Revolution in COPD Health” (TORCH) survival study is aiming to determine the impact of salmeterol/fluticasone propionate ...
Salmeterol and Fluticasone Propionate and Survival in Chronic ... 2007年2月22日 - ... Julie C. Yates, B.S., and Jørgen Vestbo, M.D. for the TORCH investigators ... Figure 1 Enrollment of Patients and Completion of the Study.
The TORCH (towards a revolution in COPD health) survival study ... Eur Respir J. 2004 Aug;24(2):206-10. The TORCH (towards a revolution in COPD health) survival study protocol. Vestbo J(1); TORCH Study Group. Author ...
Cardiovascular events in patients with COPD: TORCH study results. Cardiovascular events in patients with COPD: TORCH study results. Calverley PM(1), Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Crim C, Willits ...
[Clinical study of the month: the TORCH study (TOwards a ... The TORCH study (Towards a Revolution in COPD Health) was a double-blind, randomised, placebo-controlled clinical trial, investigating the combination of ...
lessons from the TORCH and UPLIFT® studies - National Center for ... 2009年5月7日 - The Towards a Revolution in COPD Health (TORCH) trial was a 3-year, double- blind, parallel-group, placebo-controlled study of 6184 COPD ...
TORCH - Wiki Journal Club 2012年9月16日 - The TORCH and UPLIFT trials are among the largest COPD trials ever ... During the 3 years of study, combination therapy was associated with ...
Respiratory Research | Full text | Health status in the TORCH study ... 2011年5月31日 - To examine health status changes over 3 years in the TORCH study of salmeterol +fluticasone propionate (SFC) vs. salmeterol alone, ...
COPD - American Thoracic Society The TORCH study randomized over 6,000 patients with baseline FEV1 < 60% predicted to placebo vs. salmeterol alone vs. fluticasone alone vs. a combination ...
